Literature DB >> 11779329

Secondary primary malignancies in head and neck squamous cell carcinoma.

M A Rafferty1, T P O'Dwyer.   

Abstract

Second primary malignancies pose a significant clinical challenge to the head and neck oncologist. The prognosis for these patients is poor and therefore early detection of these tumours is essential. There are considerable differences in the reported cohorts of patients and the biological behaviour of these tumours throughout the world literature. This is particularly marked when there is considerable demographic variation present. The behaviour of second primary malignancies in 425 Irish patients with head and neck cancer was reviewed retrospectively. The overall incidence of second cancers was 8.5 per cent. There were a higher proportion of oral cancer patients 47 per cent, the second cancers overall presented with a more advanced T stage, and the overall five-year survival was much lower than that of the index tumour.

Entities:  

Mesh:

Year:  2001        PMID: 11779329     DOI: 10.1258/0022215011909567

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.

Authors:  Jeffrey C Liu; Shobha Parajuli; Elizabeth Blackman; Denise Gibbs; Ashley Ellis; Anna Hull; J Robert Beck; Veda Giri; Patrick Iherjirka; Jasvir S Khurana; Camille R Ragin
Journal:  Head Neck       Date:  2015-07-18       Impact factor: 3.147

2.  HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.

Authors:  Justin A Bishop; Takenori Ogawa; Xiaofei Chang; Peter B Illei; Edward Gabrielson; Sara I Pai; William H Westra
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

Review 3.  Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients.

Authors:  Chen-Shuan Chung; Li-Jen Liao; Chia-Yun Wu; Wu-Chia Lo; Chen-Hsi Hsieh; Tzong-His Lee; Chao-Yu Liu; Deng-Yu Kuo; Pei-Wei Shueng
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

4.  Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer.

Authors:  Eui Bae Kim; Yong Park; Seh Jong Park; Dae Sik Kim; Jee Won Kim; Hee Yun Seo; Hwa Jung Sung; In Keun Choi; Kyong Hwa Park; Sang Cheul Oh; Chul Won Choi; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim; Sang Won Shin; Chul Yong Kim; Kwang-Yoon Jung
Journal:  Cancer Res Treat       Date:  2008-12-31       Impact factor: 4.679

5.  Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.

Authors:  Shih-Wei Wang; Leong-Perng Chan; Ling-Feng Wang; Che-Wei Wu; Sheng-Hsuan Lin; Tzu-Yen Huang; Ka-Wo Lee
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.